Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Nov 7 - Nov 12
peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events
They observed elevated urinary excretion rates of certain sugars in children with eczema compared to controls, indicating increased permeability of the gut barrier
Dihexa shows cognitive enhancement at picomolar concentrations, making it approximately ten million times more potent than brain-derived neurotrophic factor in some synaptogenesis assays
The lowered absorption rate and increased frequency attributed to oral supplements can cause the overall treatment process to be slower than that of B12 injections
Additionally, the combined effects of oxidative stress and excitotoxicity activate both caspase-dependent and caspase-independent apoptotic pathways, leading to cellular fragmentation and neurodegeneration
